NEW YORK, NY / ACCESSWIRE / July 20, 2018 / Pawar Law Group announces it is investigating possible securities claims on behalf of Mednax, Inc. (NYSE: MD) investors resulting from allegations that Mednax may have issued materially misleading business information to the investing public.
On July 28, 2017, Mednax announced during its second quarter earnings call that it had not completed acquisitions of anesthesiologist practices during the quarter and that any future anesthesiologist acquisitions were unlikely. On this news, Mednax's stock price fell $8.76 per share or 15.5% to close at $47.73 per share on July 28, 2017.
Pawar Law Group is preparing a class action lawsuit to recover losses suffered by Mednax investors. If you purchased shares of Mednax please visit the firm's website at http://pawarlawgroup.com/cases/mednax-inc/ to join the class action. You may also contact Vik Pawar of Pawar Law Group toll free at 888-589-9804 or via email at vik@pawarlawgroup.com.
Pawar Law Group represents investors from around the world.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Vik Pawar, Esq.
Pawar Law Group P.C
20 Vesey Street Suite 1210
New York, NY 10007
Tel: (917) 261-2277
Toll Free: 888-589-9804
Fax: (212) -571-0938
vik@pawarlawgroup.com
www.pawarlawgroup.com
SOURCE: Pawar Law Group
